NEW YORK, September 23, 2015 /PRNewswire/ --
ACI Association has initiated research coverage on the following
equities: American Capital Agency Corp. (NASDAQ:
AGNC), Apollo Investment Corporation (NASDAQ: AINV),
American Capital, Ltd. (NASDAQ: ACAS), Amgen Inc.
(NASDAQ: AMGN), Biogen Inc. (NASDAQ: BIIB). On Tuesday, September 22, 2015, NASDAQ ended at
4,756.72 down 1.50%, DOW declined 1.09%, to finish the day at
16,330.47, and the S&P closed at 1,942.74, down 1.23%. Register
for your complimentary reports at the links given below.
--
American Capital Agency Corp
--
American Capital Agency Corp's stock edged lower by 1.32% to
close Tuesday's session at USD 19.46.
The company's shares oscillated between USD
19.45 and USD 19.67. The stock recorded a trading volume of
2.45 million shares, which was below its 50-day daily average
volume of 3.51 million shares. Over the last three days, American
Capital Agency Corp's shares have advanced 0.08% and in the past
one week it has moved up 2.26%. On a compounded total return basis,
the company has returned 0.66% in the past one month, and 1.33% in
the past three months. American Capital Agency Corp has a current
dividend yield of 12.17%. Further, the company is trading at a
price to earnings ratio of 64.87 and at a price to book ratio of
0.81. Sign up and read the free notes on AGNC at:
http://www.aciassociation.com/AGNC.pdf
--
Apollo Investment Corp
--
The stock of Apollo Investment Corp lost 1.02% to close
Tuesday's session at USD 5.85. A
trading volume of 2.31 million shares was recorded, which was
greater than its 150-day daily average volume of 1.46 million
shares. Over the last five days, Apollo Investment Corp's shares
have declined by 7.44% and in the past one month, it has lost
9.86%. The stock has shown a negative return of 17.35% in the last
three months, on a compounded total return basis. Apollo Investment
Corp has a current dividend yield of 13.54%. The company is trading
at a price to earnings ratio of 83.57, compared to a historical PE
ratio of 22.54. Further, the stock is at a price to book ratio of
0.73, while the historical PB ratio is near to 0.94. Register for
free on Equity Research Institute and access the latest research on
AINV at: http://www.aciassociation.com/AINV.pdf
--
American Capital Ltd
--
American Capital Ltd's stock decreased by 1.24% to close
Tuesday's session at USD 12.74. A
total of 2.23 million shares exchanged hands, which surpassed its
50-day daily average volume of 1.68 million shares. Over the last
three days American Capital Ltd's shares have declined by 2.00% and
in the past one week it has moved down 2.52%. The stock has shown a
negative return of 9.06% in the past three months, on a compounded
total return basis. Further, the company is trading at a price to
earnings ratio of 15.54, compared to a historical PE ratio of 9.45.
The stock is at a price to book ratio of 0.63, while the historical
PB ratio is near to 0.71. Additionally, the stock is trading at a
price to cash flow ratio of 19.38 and price to sales ratio of
11.15. The complete research on ACAS is available for free at:
http://www.aciassociation.com/ACAS.pdf
--
Amgen Inc
--
Amgen Inc's stock slipped by 0.79% to close Tuesday's session at
USD 145.93. The company's shares
oscillated between USD 142.82 and USD
146.78. The stock recorded a trading volume of 4.52 million
shares, which was above its 50-day daily average volume of 3.93
million shares. Over the last three days, Amgen Inc's shares have
declined by 5.18% and in the past one week, it has lost 4.08%. The
stock has shown a negative return of 5.97% in the past one month,
on a compounded total return basis. Further, the company is trading
at a price to earnings ratio of 19.33, compared to a historical PE
ratio of 23.78. The stock is at a price to book ratio of 4.03,
while the historical PB ratio is near to 4.70. Free in-depth
research on AMGN is available at:
http://www.aciassociation.com/AMGN.pdf
--
Biogen Inc
--
Biogen Inc's stock advanced 0.64% to close Tuesday's session at
USD 299.06. The stock recorded a
trading volume of 4.39 million shares, which was above its 50-day
daily average volume of 2.95 million shares. Over the last three
days Biogen Inc's shares have declined by 8.07% and in the past one
week it has moved down 6.50%. On a compounded total return basis,
the stock has returned 1.16% in the past one month, but has shown a
negative return of 28.38% in the past three months. The company is
trading at a price to earnings ratio of 20.23, compared to a
historical PE ratio of 27.43. Further, the stock is at a price to
book ratio of 5.59, while the historical PB ratio is near to 7.37.
Additionally, the stock is trading at a price to cash flow ratio of
17.02. The complimentary notes on BIIB can be downloaded in PDF
format at: http://www.aciassociation.com/BIIB.pdf
--
About ACI Association:
Active Charter Investors Association ("ACI Association")
produces regular sponsored and non-sponsored reports, articles,
stock market blogs, and popular investment newsletters covering
equities listed on NYSE and NASDAQ and micro-cap stocks. ACI
Association has two distinct and independent departments. One
department produces non-sponsored analyst certified content
generally in the form of press releases, articles and reports
covering equities listed on NYSE and NASDAQ and the other produces
sponsored content (in most cases not reviewed by a registered
analyst), which typically consists of compensated investment
newsletters, articles and reports covering listed stocks and
micro-caps. Such sponsored content is outside the scope of
procedures detailed below.
ACI Association has not been compensated; directly or
indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by
a writer (the "Author") and is fact checked and reviewed by a third
party research service company (the "Reviewer"). Rohit Tuli, a CFA® charter holder (the
"Sponsor"), provides necessary guidance in preparing the document
templates. The Reviewer has reviewed and revised the content, as
necessary, based on sound investment judgment and publicly
available information which is believed to be reliable. The
Reviewer and the Sponsor have not performed any independent
investigations or forensic audits to validate the information
herein. Unless otherwise noted, any content outside of this
document has no association with the Author, the Reviewer, or the
Sponsor (collectively referred to as the "Production Team") in any
way. The Production Team is compensated on a fixed monthly basis
and do not hold any positions of interest in any of the securities
mentioned herein.
NO WARRANTY
ACI Association, the Author, the Reviewer and the Sponsor
(collectively referred to as the "Publishers") are not responsible
for any error which may be occasioned at the time of printing of
this document or any error, mistake or shortcoming. No liability is
accepted by the Publishers whatsoever for any direct, indirect or
consequential loss arising from the use of this document. The
Publishers expressly disclaim any fiduciary responsibility or
liability for any consequences, financial or otherwise arising from
any reliance placed on the information in this document.
Additionally, the Publishers do not (1) guarantee the accuracy,
timeliness, completeness or correct sequencing of the information,
or (2) warrant any results from use of the information. The
included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or
a solicitation of an offer to buy or sell the securities mentioned
or discussed, and is to be used for informational purposes only.
Please read all associated disclosures and disclaimers in full
before investing. Neither ACI Association nor any party affiliated
with us is a registered investment adviser or broker-dealer with
any agency or in any jurisdiction whatsoever. To download our
report(s), read our disclosures, or for more information, visit
http://www.aciassociation.com/.
RESTRICTIONS
ACI Association is not available to residents of Belarus, Cuba, Canada,
Iran, North Korea, Sudan, Syria
or Somalia.
CFA® and Chartered Financial Analyst® are registered trademarks
owned by CFA Institute.
SOURCE www.aciassociation.com